Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines

Nephrol Dial Transplant. 2022 Mar 25;37(4):796-798. doi: 10.1093/ndt/gfab324.
No abstract available

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Immunity, Cellular
  • Renal Dialysis / adverse effects
  • SARS-CoV-2
  • Vaccination / adverse effects
  • mRNA Vaccines*

Substances

  • COVID-19 Vaccines
  • mRNA Vaccines